Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia
- 8/21/2026 2:28:48 PM
- The U.S. Food and Drug Administration today issued an accelerated approval for Genglycos (pariglasgene brecaparvovec-opnr) to reduce daily cornstarch intake as an adjunct to nutritional management in adults and pediatric patients 8 years of age and older with glycogen storage disease type Ia (GSDIa), a rare, inherited genetic disorder caused by a deficiency of the enzyme …
- Hundreds of health and nutrition facilities closed as Somalia’s child crisis deepens
- 8/21/2026 1:28:09 PM
- “In Somalia today, aid cuts are closing doors to healthcare, shutting down nutrition services, and pushing water, education and protection further out of reach.
- Ebola in DR Congo: 180 Children Have Lost Both Caregivers 100 Days Into Outbreak
- 8/21/2026 12:53:19 PM
- At least 180 children have lost both parents or primary caregivers in the Democratic Republic of Congo (DRC) since the Ebola outbreak was declared 100 days ago.[1] Thousands more children have lost one parent or caregiver, exposing them to heightened risks of abuse, exploitation, trafficking and severe psychological distress as families and already fragile social …
- Children account for half of suspected mpox cases in Guinea-Bissau
- 8/20/2026 9:09:01 AM
- Children under 15 account for half of all 46 suspected mpox cases in Guinea-Bissau. UNICEF is scaling up its support to the Ministry of Public Health in direct response to the country’s first-ever mpox outbreak.
- WHO and Africa CDC welcome the allocation of Ebola vaccines to the Democratic Republic of the Congo
- 8/20/2026 8:51:47 AM
- Last week, the government of the Democratic Republic of the Congo (DRC) requested a release of Ervebo vaccines from the global Ebola virus disease vaccine stockpile, managed by the International Coordinating Group on Vaccine Provision (ICG).
- Johnson & Johnson Announces MONARCH™ QUEST 3, Advancing the Latest in Robotically-Assisted Bronchoscopy
- 8/20/2026 8:05:04 AM
- Johnson & Johnson today announced U.S. 510(k) regulatory clearance for MONARCH ™ QUEST 3, the latest software update for the MONARCH Platform. The update reflects the company’s continued commitment to advancing its first‑to-market robotically-assisted bronchoscopy platform guided by clinician experience and focused on improving confidence during complex procedures.
- GE HealthCare appoints William Grogan as Chief Financial Officer
- 8/19/2026 12:46:04 PM
- GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, announced the appointment of William (Bill) Grogan as Chief Financial Officer, effective September 14, 2026.
- IFC, Popular Pharmaceuticals Partner to Boost Bangladesh’s Healthcare Supply Chains and Create Jobs
- 8/19/2026 12:39:15 PM
- To help safeguard the continuity of essential medicines and support job creation in Bangladesh, IFC, a member of the World Bank Group focused on the private sector, has committed a US$ 30.7 million senior secured loan to Popular Pharmaceuticals PLC (Popular), a leading manufacturer of generic medicines.
- Can antioxidant foods help prevent cervical cancer?
- 8/19/2026 10:59:24 AM
- In the study, investigators analyzed 2003–2018 data from 1,044 US women participating in the National Health and Examination Survey: 174 with and 870 without cervical cancer.
- Oracle Health Expands Clinical AI Agent with Automated Coding, Dictation, and Chart Review
- 8/19/2026 10:01:03 AM
- Oracle Health announced new capabilities for Oracle Health Clinical AI Agent, now available in the U.S., that expand AI across clinical documentation, coding, and chart review workflows.
- WHO/UNICEF report highlights gaps in health facility sanitation
- 8/19/2026 9:49:32 AM
- A new WHO and UNICEF report reveals significant gaps in essential water, sanitation, hygiene and environmental health services in health-care facilities worldwide.
- RHS urges Britain to make autumn as important as spring for planting as drought and heatwaves put gardens under pressure
- 8/19/2026 8:48:28 AM
- Trees, shrubs and climbers provide shade and are vital natural air conditioners, but spring-planted trees can be quickly exposed to heatwaves and dry spells before their roots are established.
- Johnson & Johnson Publishes New Future of Digital Surgery Report to Help Define the Emerging Field of Surgical Intelligence
- 8/18/2026 3:46:59 PM
- Johnson & Johnson today announced the publication of its latest Future of Digital Surgery report, Surgery’s Next Inflection Point: The Rise of Surgical Intelligence, making the case that healthcare is entering a new era where connected data, artificial intelligence and intelligent systems will fundamentally reshape surgery.
- Mitsui Chemicals Completes Acquisition of U.S.-based Ultradent
- 8/18/2026 3:07:17 PM
- Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: ICHIMURA Satoshi) previously announced in a June 12, 2026 disclosure titled “Notice Regarding the Planned Execution of Agreements to Acquire Ultradent Products, Inc.” that it would acquire Ultradent Products, Inc.
- On prior auth, CMS responds to AMA concerns
- 8/18/2026 2:45:19 PM
- The American Medical Association (AMA) welcomed updated guidance from the Centers for Medicare & Medicaid Services (CMS) that strengthens enforcement of federal prior authorization transparency requirements, addressing concerns the AMA raised about how health plans were making required information available to patients and physicians.
- Update on eVOLVE-Lung02 Phase III trial of volrustomig plus chemotherapy in metastatic non-small cell lung cancer
- 8/18/2026 2:35:35 PM
- AstraZeneca is discontinuing the eVOLVE-Lung02 Phase III trial evaluating volrustomig in combination with chemotherapy as a 1st-line therapy compared to pembrolizumab and chemotherapy in patients with metastatic non-small cell lung cancer (mNSCLC) whose tumours express PD-L1 less than 50%.
- Research Points to New Therapies to Lessen the Severity of Delusions for Patients with Schizophrenia
- 8/18/2026 1:19:21 PM
- New research has found that improvements to the severity of delusions in patients with schizophrenia-spectrum disorder recovering from an acute psychotic episode were significantly associated with reductions in volatility priors—someone’s expectations about the unpredictability of their environment.
- High-speed microscopy reveals electrical activity across the brain
- 8/17/2026 4:37:42 AM
- Within the brain, neurons compute by generating electrical impulses. These signals travel throughout neurons, which are in turn connected in vast networks that control brain functions such as sensory perception, memory formation, and control of movement.
- Robert Reyes Challenges Conventional Neural Theory of Vision With a Holographic Framework at MIBF 2026
- 8/13/2026 5:08:02 PM
- Independent researcher and author Robert Reyes will have his book, “The Human Holographic Visual System,” showcased at the 2026 Manila International Book Fair, bringing a provocative question to readers: does the prevailing neural theory fully explain how visual images are produced in the brain? Reyes recently submitted an article to Skeptical Inquirer Magazine and is …
- Building the New: How a Lyme Patient Advocate Landed in the NIH Director’s Office
- 8/13/2026 9:00:00 AM
- At 7:00 a.m. on Monday, March 16, 2026, Bruce Fries, President of the Patient Centered Care Advocacy Group, emailed NIH Director Dr. Jay Bhattacharya with a comprehensive proposal: Strengthening NIH Research Standards: A Framework for Scientific Integrity, Transparency and Stakeholder Engagement.